$107.94 0%
Price vs. AI Score (Last 150 days)
Data gathered: December 9

Data Bits

Data Bits Value / Change Benchmark
Job Posts 4,900 0%
Sentiment 90 0%
Webpage traffic 910,000 -10.7%
Employee Rating 67 -1.5%
Google Adspend $34,593 23.2%
Google Trends 24 -67.6%
Linkedin Employees 34,499 N/A
Patents 0% N/A
4chan Mentions 0% N/A
Facebook Engagement 929 -0.9%
Facebook followers 122,577 -0%
Stocktwits Mentions 2 0%
Stocktwits Subscribers 1,993 0.1%
Twitter Followers 15,068 N/A
Youtube Subscribers 39,300 0%
Instagram Followers 20,153 0%
News Mentions 0%
Reddit Mentions 0% N/A
Business outlook 52 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About DaVita

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States.

Price $107.94
Target Price Sign up
Market Cap $9.69B
Dividend Yield 0.11
Industry Medical Care Facilities

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '233.12B565M2.56B247M684M
Q2 '233B548M2.45B179M589M
Q1 '232.87B510M2.36B116M490M
Q4 '222.92B574M2.34B68M450M
Q3 '222.95B560M2.39B105M506M

Insider Transactions

Waters Kathleen Alyce filed to sell 81,297 shares at $101.8.
August 24 '23
YALE PHYLLIS R filed to sell 13,110 shares at $95.3.
May 12 '23
HEARTY JAMES O filed to sell 32,559 shares at $101.6.
May 12 '23
Waters Kathleen Alyce filed to sell 91,245 shares at $99.2.
May 12 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.